Search

Your search keyword '"Atherosclerosis -- Drug therapy"' showing total 631 results

Search Constraints

Start Over You searched for: Descriptor "Atherosclerosis -- Drug therapy" Remove constraint Descriptor: "Atherosclerosis -- Drug therapy"
631 results on '"Atherosclerosis -- Drug therapy"'

Search Results

1. New Atherosclerosis Data Have Been Reported by Investigators at Institute of Medicinal Biotechnology (Antirheumatic Drug Leflunomide Attenuates Atherosclerosis By Regulating Lipid Metabolism and Endothelial Dysfunction Via Dhodh/ampk Signaling ...)

2. Researcher at Department of Internal Medicine Targets Artificial Intelligence (Artificial Intelligence in Cardiology and Atherosclerosis in the Context of Precision Medicine: A Scoping Review)

4. Findings from Department of Medicine Provides New Data about Atherosclerosis [A New Co(Ii) Coordination Polymer: Application Values On Atherosclerosis By Reducing the Inflammatory Response]

5. Research on Atherosclerosis Published by Researchers at Nanjing University (Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US Adults, 1999-2018)

6. University of Pittsburgh School of Medicine Researchers Provide New Insights into Alzheimer Disease (Cardiovascular Disease and Alzheimer's Disease: The Heart-Brain Axis)

7. Hubei University of Medicine Researchers Describe Recent Advances in Cardiovascular Diseases and Conditions (MiR-483-5p downregulation alleviates ox-LDL induced endothelial cell injury in atherosclerosis)

8. Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS Researchers Have Published New Study Findings on Biomedicine and Pharmacotherapy (AEE alleviates ox-LDL-induced lipid accumulation and inflammation in macrophages)

9. University Hospital Dusseldorf Researchers Highlight Research in Bioprosthetics (Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model)

10. Findings from Sri Aurobindo Institute of Pharmacy Broaden Understanding of Obesity (A Review on Pharmacological and Non-Pharmacological Therapy for the treatment of Obesity with Cardiovascular Diseases)

11. George Emil Palade University of Medicine Researcher Provides New Insights into Atherosclerosis (Short-Term Atorvastatin Therapy in Healthy Individuals Results in Unaltered Plasma MMP Levels and Disrupted MMP-7 Correlation with Blood Lipids and ...)

12. Versiti Blood Research Institute Researchers Describe Research in Cardiovascular Medicine (CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesis)

13. Researchers at Indian Institute of Technology (IIT) Kharagpur Release New Data on Atherosclerosis (Atorvastatin-based Nanoparticle-decorated Glyceryl Monostearate As a Targeted Drug Carrier for Inhibition of Atherosclerosis Lesions)

15. Study Results from Section on Hospital Medicine in the Area of Atherosclerosis Published (Association Between Alcohol Consumption and Ectopic Fat in the Multi-Ethnic Study of Atherosclerosis)

16. New Atherosclerosis Study Findings Have Been Reported from Griffith University (Targeting Endothelial Vascular Cell Adhesion Molecule-1 In Atherosclerosis: Drug Discovery and Development of Vascular Cell Adhesion Molecule-1-directed Novel ...)

18. Leiden University Researcher Publishes New Data on Atherosclerosis (Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility)

19. Clinical Medicine Research Center Reports Findings in Atherosclerosis (Relationship between atherosclerotic burden and depressive symptoms in hypertensive patients: A cross-sectional study based on the NHANES database)

20. Research Data from Wujin Hospital Affiliated with Jiangsu University Update Understanding of Atherosclerosis (Non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates for the treatment of atherosclerosis and vascular ...)

22. Findings from Johns Hopkins University Has Provided New Data on Diabetes Mellitus (Subclinical Atherosclerosis To Guide Treatment In Dyslipidemia and Diabetes Mellitus)

23. Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023

24. One single 'nanodrug' could help treat 2 of UK's biggest killer diseases, experts say; The drugs fight tumours by targeting the body's own immune cells -but these tiny 'trojan horses' could treat both cancer and heart disease in future Dr Bryan Smith said

25. Reports on Atherosclerosis Findings from University of Houston Provide New Insights (2022 Acc Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: a Framework for Pragmatic, ...)

26. Novartis Pharmaceuticals Corporation Researchers Discuss Findings in Preventive Cardiology [Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study]

27. New Atherosclerosis Findings from Nanchang University Described (Dual-responsive Targeted Atherosclerosis Therapy Through a Multi-effective Nanoplatform With Anti-inflammatory, Lipid-regulating and Autophagy)

28. Emory University Researcher Focuses on Atherosclerosis (Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016)

29. University College Dublin Researcher Focuses on Obesity and Diabetes (The Role of Nano-systems in the Delivery of Glucose-lowering Drugs for the Pre-emption and Treatment of Diabetes-associated Atherosclerosis)

31. Institute for Cancer Research and Treatment (IRCCS) Researcher Updates Current Data on Primary Hyperparathyroidism (Carotid Intima-Media Thickness in Surgically or Conservatively Managed Patients With Primary Hyperparathyroidism)

32. New Atherosclerosis Data Have Been Reported by Investigators at Victor Babes University of Medicine and Pharmacy (Surface-modified Polyurethane Structures Used As a Carrier for Simvastatin for the Possible Treatment of Atherosclerosis In ...)

33. Division of Cardiovascular Medicine Researchers Yield New Data on Heart Disease (Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients With Chronic Coronary Syndrome)

34. Researchers' Work from Aristotle University of Thessaloniki Focuses on Atherosclerosis (The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis)

35. Atherosclerosis Drugs Market to be Worth US$ 62.8 Billion by 2033: Fact.MR Report

36. Atherosclerosis Drugs Market to be Worth US$ 62.8 Billion by 2033: Fact.MR Report

37. New Atherosclerosis Findings from University of Medicine and Pharmacy 'Grigore T. Popa' Published (Circulating Biomarkers for Laboratory Diagnostics of Atherosclerosis-Literature Review)

38. Researchers' Work from Zhejiang University School of Medicine Focuses on Atherosclerosis (Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects)

39. New Atherosclerosis Study Findings Have Been Reported from La Trobe University (Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis)

40. Data from First Affiliated Hospital of Nanjing Medical University Broaden Understanding of Cardiovascular Medicine [LINC00452 overexpression reverses oxLDL-induced injury of human umbilical vein endothelial cells (HUVECs) via regulating ...]

41. Studies from Anhui University of Chinese Medicine in the Area of Atherosclerosis Published (Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology)

42. Findings from Hebei University Update Knowledge of Atherosclerosis (Potential Active Compounds and Molecular Mechanism of Xuefu Zhuyu Decoction for Atherosclerosis, Based On Network Pharmacology and Molecular Docking)

43. Researchers at Kobe University Graduate School of Medicine Have Published New Data on Hypercholesterolemia (Depletion of Foxp3+ regulatory T cells augments CD4+ T cell immune responses in atherosclerosis-prone hypercholesterolemic mice)

44. Global Atherosclerosis Drug Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023

45. Global Atherosclerosis Drugs Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023

46. Nanoagent-based three-method treatment for atherosclerosis: Combination of thermal, mechanical, and drug-based methods

47. Atherosclerosis Drugs Market Size is expected to reach USD 26.9 Billion by 2032

48. Atherosclerosis Drugs Market Size is expected to reach USD 26.9 Billion by 2032, registering a CAGR of 2.8% from 2023 to 2032

49. Atherosclerosis Drugs Market Size is expected to reach USD 26.9 Billion by 2032, registering a CAGR of 2.8% from 2023 to 2032

Catalog

Books, media, physical & digital resources